-
Parexel Launches COVID-19 Risk Mitigation Offering
contractpharma
May 14, 2020
Four-step methodology aims ensure manufacturers can safely continue manufacturing operations through the COVID-19 pandemic.
-
Parexel Adds Experts to Regulatory Consulting Group
ContractPharma
December 11, 2019
Four new hires from U.S. FDA and MHRA will serve as technical vice presidents.
-
Parexel expands Ph I research capabilities in China
biospectrumasia
September 19, 2019
Parexel recently was recognized as a leader in Phase I clinical development by Industry Standard Research in its 2019 CRO Quality Benchmarking Report. The company has eight offices and more than 1,700 employees across all functions in Greater China as wel
-
Parexel launches Health Advances Asia, expanding global footprint with Hong Kong, S.A.R., China base
fiercepharma
July 28, 2019
The so-called Health Advances Asia Limited subsidiary, which forms part of Parexel's consulting unit, is set up to “support development of global expansion strategies for Asia/Pacific and multinational companies from new Hong Kong, S.A.R., China presence,
-
Parexel to Collaborate with CluePoints
contractpharma
June 20, 2019
Aims to drive the quality, accuracy, and integrity of clinical trial data as well as increase productivity, efficiency and cost effectiveness for sponsors.
-
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP)
b3cnewswire
April 17, 2019
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP)
-
NIHR’s Clinical Research Network links with PAREXEL in the North West
pharmatimes
December 20, 2018
The National Institute for Health Research (NIHR) has a new partnership agreement signed between the Clinical Research Network: North West Coast (CRN:NWC) and PAREXEL.
-
SHYFT Analytics, PAREXEL Enter Strategic RWE Pact
contractpharma
November 13, 2018
SHYFT Analytics, PAREXEL Enter Strategic RWE Pact
-
PAREXEL expands regulatory management services
biospectrumasia
October 23, 2018
PAREXEL partners with EMC to provide regulatory management services
-
PAREXEL Advances Patient-Centric Drug Development with Introduction of Its Patient Innovation Center
pharmafocusasia
September 13, 2018
PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas o